Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Director departure
Inv. presentation
Quarterly results

Carlyle Group Inc. (CG) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 SC 13D/A Carlyle Group Inc. reports a 10% stake in Soleno Therapeutics, Inc.
10/02/2023 4 Carlyle Group Inc. (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Converted 329,930 shares @ $1.75, valued at $577.4k
Converted 1,092,056 options to buy @ $1.75, valued at $1.9M
Converted 762,126 options to buy @ $0.01, valued at $7.6k
10/02/2023 3 Redett John C. (CFO) has filed a Form 3 on Carlyle Group Inc.
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2023 4 SCHWARTZ HARVEY M (CEO) has filed a Form 4 on Carlyle Group Inc.
Txns: Granted 80,717 shares @ $0
08/18/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/18/2023 SC 13D/A Carlyle Group Inc. reports a 12.3% stake in Soleno Therapeutics, Inc.
08/04/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/03/2023 4 Finn Christopher (COO) has filed a Form 4 on Carlyle Group Inc.
Txns: Sold 27,067 shares @ $32.36, valued at $875.9k
08/03/2023 4 Buser Curtis L. (CFO) has filed a Form 4 on Carlyle Group Inc.
Txns: Sold 25,828 shares @ $32.36, valued at $835.8k
08/03/2023 4 Larson Bruce M. (Chief Human Resources Officer) has filed a Form 4 on Carlyle Group Inc.
Txns: Sold 13,413 shares @ $32.36, valued at $434k
08/03/2023 4 Andrews Charles Elliott Jr. (Chief Accounting Officer) has filed a Form 4 on Carlyle Group Inc.
Txns: Sold 6,669 shares @ $32.36, valued at $215.8k
08/03/2023 4 Ferguson Jeffrey W. (General Counsel) has filed a Form 4 on Carlyle Group Inc.
Txns: Sold 11,939 shares @ $32.36, valued at $386.3k
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 SC 13D/A Carlyle Group Inc. reports a 4.2% stake in Vera Therapeutics, Inc.
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
07/17/2023 SC 13D/A Carlyle Group Inc. reports a 8.1% stake in Carlyle Credit Income Fund
07/05/2023 SC 13D/A Carlyle Group Inc. reports a 5.5% stake in Vera Therapeutics, Inc.
07/05/2023 4 Carlyle Group Inc. (10% Owner) has filed a Form 4 on CommScope Holding Company, Inc.
Txns: Acquired 15,337 convertible preferred @ $0
06/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/05/2023 4 Cherwoo Sharda (Director) has filed a Form 4 on Carlyle Group Inc.
Txns: Granted 5,709 shares @ $0
06/05/2023 3 Cherwoo Sharda (Director) has filed a Form 3 on Carlyle Group Inc.
06/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF",
"THE CARLYLE GROUP INC. AMENDED AND RESTATED 2012 EQUITY INCENTIVE PLAN"
05/25/2023 4 SCHWARTZ HARVEY M (CEO) has filed a Form 4 on Carlyle Group Inc.
Txns: Granted 85,723 shares @ $0
05/10/2023 4 Carlyle Group Inc. (10% Owner) has filed a Form 4 on MKS INSTRUMENTS INC
Txns: Sold 2,000,000 shares @ $86.125, valued at $172.3M
05/10/2023 SC 13D/A Carlyle Group Inc. has filed a Schedule 13D for Soleno Therapeutics, Inc.
05/10/2023 4 Carlyle Group Inc. (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC
Txns: Bought 1,092,056 options to buy @ $1.75, valued at $1.9M
Bought 1,778,000 options to buy @ $2.5, valued at $4.4M
05/09/2023 SC 13D/A Carlyle Group Inc. reports a 8.2% stake in Reneo Pharmaceuticals, Inc.
05/05/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy